CARDIOVASCULAR DISEASE BOARD EXAM PREP
Register Now – Start Anytime
- Earn up to 140.5 AMA PRA Category 1 Credits™ and 102 ABIM MOC Points
- Gets you ready with a deep QBank of 1300+ practice questions in board format
- Enhances your learning with high-yield online videos presented by board-focused faculty
- Saves time by following the ABIM Cardiovascular Disease board exam topic blueprint
- Fits your busy schedule with anytime, anywhere access
- Includes detailed, illustrated study guide
- Guarantees you′ll pass with The Triple Trust Guarantee
What are the 2023 Cardiovascular Disease Board Pass Rates?
The ABIM 2023 Cardiovascular Disease Pass Rate for the Initial Certification exam is 86%.
The ABIM 2023 Cardiovascular Disease Pass Rate for the Maintenance of Certification exam is 86%.
Compare to exam takers who prepared with The Pass Machine:
In 2023, The Pass Machine Cardiovascular Disease Board Review clients achieved a 91% pass rate on the Maintenance of Certification exam!
1 out of 7 Physicians Failed
Cardiovascular Disease is among the more challenging ABIM board exams. Last year, 157 out of 1121 first-time takers failed the Cardiology Cert exam. 10-Year MOC exam takers did better.
Exam Prep Works
American Board of Internal Medicine recognizes “Exam Prep” as the primary step toward certification. Their Study of Studying infographic reminds us of the acute benefits of using board exam prep as a review and assessment tool.
Pass Guaranteed
The #1 Guarantee in Board Prep for Physicians! The Triple Trust Guarantee from American Physician Institute has your back. As you see from our clients’ board results above, investing in a comprehensive review course pays off.
What do I do if I fail the Cardiology board exam?
The first thing you should do is just take it easy, sleep on it. Give yourself a few days, a week or two to come to terms with what has happened. Your next exam is six months to a year away. Dr. Jack has more advice in this video, What Do You Do If You Fail Your Medical Board Exam?
Cardiovascular Disease Certification Exam Scoring
Overall performance is reported on a standardized score scale ranging from 200 to 800, with a mean of 500. To pass the Cardiovascular Disease board examination, your standardized score must equal or exceed the standardized passing score. Your performance on the entire exam determines your pass-fail decision.
The passing standard for the Cardiovascular Disease exam is set by ABIM committee using standard-setting techniques that follow best practices in assessment. Because the passing standard is based on a specified level of mastery of Cardiovascular Disease content, no predetermined percentage of examinees will pass or fail the exam.
Cardiovascular Disease Certification Exam Format
The Cardiovascular Disease Certification (CERT) board exam is composed of up to 240 single-best-answer multiple-choice questions. Most questions describe patient scenarios and ask about the tasks performed by physicians in the course of practice. (Note that around 40 of these are new questions that do not count in your score.)
Example of a single-best-answer multiple-choice question format:
A 64-year-old man with a history of diabetes and hypertension presented to the clinic with stable angina. The physical exam revealed no signs of CHF. Diagnostic catheterization showed an EF of 35%. All 3 main arteries were patent with discrete 80% lesions proximally. He undergoes CABG x 3 without complication. Three weeks later, this patient comes to your office to establish care. In this case, which one of the following therapies will not reduce mortality?
◯ A. Statins
◯ B. Prophylactic ICD
◯ C. Beta-blocker
◯ D. ACEI
Correct Response:
B. Prophylactic ICD
Statins, beta-blockers, and ACEI all have studies shown to improve mortality in patients with coronary artery disease and low ejection fractions regardless of revascularization. However, a repeat ECHO is recommended in 3 months, post-CABG before this patient meets primary prevention criteria. Many people improve their cardiac function with revascularization, which improves their ejection fraction by>35%, and thus, no mortality benefit is seen. CABG-PATCH was the seminal trial that randomized patients to CABG plus ICD vs. CABG alone and showed no incremental benefit in patients who received ICD.
Source
Epstein AE, ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities Circulation:117(21) 2820.
Sub-Topic
Heart Failure and Cardiomyopathy